Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

3.13
+0.06502.12%
Volume:1.60M
Turnover:5.01M
Market Cap:478.19M
PE:-3.71
High:3.18
Open:3.08
Low:3.08
Close:3.06
52wk High:5.23
52wk Low:2.01
Shares:153.02M
Float Shares:132.00M
Volume Ratio:1.17
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8421
EPS(LYR):-0.8421
ROE:-62.50%
ROA:-36.26%
PB:2.52
PE(LYR):-3.71

Loading ...

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

GlobeNewswire
·
Dec 11, 2025

Absci Director Frans Van Houten Reports Acquisition of Common Shares

Reuters
·
Dec 10, 2025

BRIEF-Absci Announces First Participants Dosed In Phase 1/2A Headline Trial

Reuters
·
Dec 04, 2025

Absci Doses First Volunteers in Phase 1/2a Trial of AI-Designed Antibody for Hair Loss

Reuters
·
Dec 04, 2025

Absci Announces First Participants Dosed in Phase 1/2a Headline™ Trial of AI-Designed Antibody Abs-201™ for Androgenetic Alopecia

THOMSON REUTERS
·
Dec 04, 2025

Absci Corp: Interim Data Anticipated in Second Half of 2026

THOMSON REUTERS
·
Dec 04, 2025

Absci Corp - Phase 2 Development of Abs-201 in Endometriosis Planned for Q4 2026

THOMSON REUTERS
·
Dec 04, 2025

Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade

InvestorPlace
·
Dec 02, 2025

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), AbSci (ABSI) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Nov 25, 2025

Stock Track | Absci Corporation Plummets 14.85% as Q3 Results Fall Short of Expectations

Stock Track
·
Nov 13, 2025

Absci Is Maintained at Buy by Needham

Dow Jones
·
Nov 13, 2025

Stock Track | Absci Corporation Plummets 11.76% in Pre-market Following Disappointing Q3 Results

Stock Track
·
Nov 13, 2025

Stock Track | Absci Corporation Plunges 9.71% Following Disappointing Q3 Results and Revenue Miss

Stock Track
·
Nov 13, 2025

Stock Track | Absci Shares Plunge 16.77% After-Hours on Q3 Revenue Miss and Wider Losses

Stock Track
·
Nov 13, 2025

Stock Track | Absci Plunges 16.77% After-Hours on Q3 Revenue Miss and Wider-Than-Expected Losses

Stock Track
·
Nov 13, 2025

Absci reports Q3 EPS (20c), consensus (21c)

TIPRANKS
·
Nov 13, 2025

Absci Corporation Showcases AI-Powered Antibody Design and Pipeline Progress in New Presentation

Reuters
·
Nov 13, 2025

Absci reports Q3 revenue of $0.4 million and net loss of $28.7 million

Reuters
·
Nov 13, 2025

BRIEF-Absci Q3 Revenue USD 378 Thousand Vs. IBES Estimate USD 1.52 Million

Reuters
·
Nov 13, 2025

Absci Q3 Operating Expenses USD 30.532 Million

THOMSON REUTERS
·
Nov 13, 2025